Combined treatment for a combined enlargement

Area of Science:

• Cardiology
• Periodontology
• Pharmacology

Background:

• Calcium channel blockers (CCBs) are essential for managing hypertension and angina.
• Gingival overgrowth is a known side effect of certain CCBs, affecting patient quality of life and oral hygiene.
• Amlodipine, a third-generation CCB, has been linked to gingival overgrowth in limited reports.

Observation:

• This case report focuses on a hypertensive patient experiencing amlodipine-induced gingival overgrowth.
• The overgrowth created plaque retention sites, potentially increasing oral bacterial load.
• The patient's quality of life was significantly impacted by the gingival overgrowth.

Findings:

• Effective management strategies for CCB-induced gingival overgrowth were explored.
• Good oral hygiene is crucial for controlling gingival inflammation associated with CCBs.
• Surgical excision is the primary treatment for severe cases, followed by meticulous oral care.

Implications:

• Highlights the importance of monitoring for gingival overgrowth in patients using CCBs, particularly amlodipine.
• Emphasizes the need for comprehensive oral hygiene education and intervention.
• Suggests that prompt management can mitigate the negative effects of gingival overgrowth on patient health and well-being.